ANIXA BIOSCIENCES, INC. Research and Development Expense
ANIXA BIOSCIENCES, INC. (ANIX) reported Research and Development Expense of $1.33 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-09-09
- ANIXA BIOSCIENCES, INC. research and development expense for the quarter ending 2026-07-31 was $1.33M, a 25.69% increase year-over-year.
- ANIXA BIOSCIENCES, INC. research and development expense for the quarter ending 2026-04-30 was $1.26M, a 4.84% decline year-over-year.
- ANIXA BIOSCIENCES, INC. research and development expense for the quarter ending 2026-01-31 was $1.10M, a 28.99% decline year-over-year.
- ANIXA BIOSCIENCES, INC. research and development expense for the quarter ending 2025-10-31 was $1.14M, a 22.63% decline year-over-year.
- ANIXA BIOSCIENCES, INC. research and development expense for fiscal 2025 was $5.07M, a 20.72% decline from fiscal 2024.
- ANIXA BIOSCIENCES, INC. research and development expense for fiscal 2024 was $6.40M, a 34.12% increase from fiscal 2023.
- ANIXA BIOSCIENCES, INC. research and development expense for fiscal 2023 was $4.77M, a 28.85% decline from fiscal 2022.
- ANIXA BIOSCIENCES, INC. research and development expense for fiscal 2022 was $6.70M, a 8.29% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $1.33M 10-Q · filed 2026-09-09 | $2.58M derived: sum of 2 quarters · filed 2026-09-09 | $3.69M 10-Q · filed 2026-09-09 | $4.83M derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2026-04-30 | $1.26M 10-Q · filed 2026-06-10 | $2.36M 10-Q · filed 2026-06-10 | $3.50M derived: sum of 3 quarters · filed 2026-06-10 | $4.56M derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2026-01-31 | $1.10M 10-Q · filed 2026-03-09 | $2.24M derived: sum of 2 quarters · filed 2026-03-09 | $3.30M derived: sum of 3 quarters · filed 2026-09-09 | $4.62M derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2025-10-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $2.20M derived: sum of 2 quarters · filed 2026-09-09 | $3.52M derived: sum of 3 quarters · filed 2026-09-09 | $5.07M 10-K · filed 2026-01-12 | ||||
| 2025-07-31 | $1.05M 10-Q · filed 2026-09-09 | $2.38M derived: sum of 2 quarters · filed 2026-09-09 | $3.93M 10-Q · filed 2026-09-09 | $5.41M derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2025-04-30 | $1.32M 10-Q · filed 2026-06-10 | $2.87M 10-Q · filed 2026-06-10 | $4.35M derived: sum of 3 quarters · filed 2026-06-10 | $6.28M derived: sum of 4 quarters · filed 2026-06-10 | ||||
| 2025-01-31 | $1.55M 10-Q · filed 2026-03-09 | $3.03M derived: sum of 2 quarters · filed 2026-03-09 | $4.95M derived: sum of 3 quarters · filed 2026-03-09 | $6.60M derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2024-10-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $3.40M derived: sum of 2 quarters · filed 2026-01-12 | $5.05M derived: sum of 3 quarters · filed 2026-01-12 | $6.40M 10-K · filed 2026-01-12 | ||||
| 2024-07-31 | $1.93M 10-Q · filed 2025-09-10 | $3.57M derived: sum of 2 quarters · filed 2025-09-10 | $4.92M 10-Q · filed 2025-09-10 | $6.54M derived: sum of 4 quarters · filed 2025-09-10 | ||||
| 2024-04-30 | $1.65M 10-Q · filed 2025-05-28 | $3.00M 10-Q · filed 2025-05-28 | $4.61M derived: sum of 3 quarters · filed 2025-05-28 | $5.70M derived: sum of 4 quarters · filed 2025-05-28 | ||||
| 2024-01-31 | $1.35M 10-Q · filed 2025-03-11 | $2.96M derived: sum of 2 quarters · filed 2025-03-11 | $4.05M derived: sum of 3 quarters · filed 2025-03-11 | $5.05M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-10-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-10 | $2.70M derived: sum of 2 quarters · filed 2025-01-10 | $3.70M derived: sum of 3 quarters · filed 2025-01-10 | $4.77M 10-K · filed 2025-01-10 | ||||
| 2023-07-31 | $1.09M 10-Q · filed 2024-09-06 | $2.09M derived: sum of 2 quarters · filed 2024-09-06 | $3.15M 10-Q · filed 2024-09-06 | $4.84M derived: sum of 4 quarters · filed 2024-09-06 | ||||
| 2023-04-30 | $998.00K 10-Q · filed 2024-06-04 | $2.07M 10-Q · filed 2024-06-04 | $3.75M derived: sum of 3 quarters · filed 2024-06-04 | $5.20M derived: sum of 4 quarters · filed 2024-06-04 | ||||
| 2023-01-31 | $1.07M 10-Q · filed 2024-03-12 | $2.75M derived: sum of 2 quarters · filed 2024-03-12 | $4.20M derived: sum of 3 quarters · filed 2024-03-12 | $5.93M derived: sum of 4 quarters · filed 2024-03-12 | ||||
| 2022-10-31 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-16 | $3.13M derived: sum of 2 quarters · filed 2024-01-16 | $4.87M derived: sum of 3 quarters · filed 2024-01-16 | $6.70M 10-K · filed 2024-01-16 | ||||
| 2022-07-31 | $1.45M 10-Q · filed 2023-09-06 | $3.18M derived: sum of 2 quarters · filed 2023-09-06 | $5.02M 10-Q · filed 2023-09-06 | $7.19M derived: sum of 4 quarters · filed 2023-09-06 | ||||
| 2022-04-30 | $1.74M 10-Q · filed 2023-06-14 | $3.57M 10-Q · filed 2023-06-14 | $5.75M derived: sum of 3 quarters · filed 2023-06-14 | $7.91M derived: sum of 4 quarters · filed 2023-06-14 | ||||
| 2022-01-31 | $1.84M 10-Q · filed 2023-03-17 | $4.01M derived: sum of 2 quarters · filed 2023-03-17 | $6.18M derived: sum of 3 quarters · filed 2023-03-17 | $7.20M derived: sum of 4 quarters · filed 2023-03-17 | ||||
| 2021-10-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-04 | $4.34M derived: sum of 2 quarters · filed 2023-01-04 | $5.36M derived: sum of 3 quarters · filed 2023-01-04 | $6.19M 10-K · filed 2023-01-04 | $6.19M 10-K · filed 2022-01-04 | |||
| 2021-07-31 | $2.17M 10-Q · filed 2022-09-09 | $2.17M 10-Q · filed 2021-09-01 | $3.19M derived: sum of 2 quarters · filed 2022-09-09 | $4.02M 10-Q · filed 2022-09-09 | $4.02M 10-Q · filed 2021-09-01 | $4.42M derived: sum of 4 quarters · filed 2022-09-09 | ||
| 2021-04-30 | $1.02M 10-Q · filed 2022-06-10 | $1.02M 10-Q · filed 2021-06-10 | $1.85M 10-Q · filed 2022-06-10 | $1.85M 10-Q · filed 2021-06-10 | $2.26M derived: sum of 3 quarters · filed 2022-06-10 | $3.51M derived: sum of 4 quarters · filed 2022-06-10 | ||
| 2021-01-31 | $828.00K 10-Q · filed 2022-03-11 | $827.65K 10-Q · filed 2021-03-11 | $1.24M derived: sum of 2 quarters · filed 2022-03-11 | $2.49M derived: sum of 3 quarters · filed 2022-03-11 | $3.72M derived: sum of 4 quarters · filed 2022-03-11 | |||
| 2020-10-31 | $407.70K derived: 10-K 12 month − 10-Q 9 month · filed 2022-01-04 | $1.66M derived: sum of 2 quarters · filed 2022-01-04 | $2.89M derived: sum of 3 quarters · filed 2022-01-04 | $4.38M 10-K · filed 2022-01-04 | ||||
| 2020-07-31 | $1.25M 10-Q · filed 2021-09-01 | $2.48M derived: sum of 2 quarters · filed 2021-09-01 | $3.97M 10-Q · filed 2021-09-01 | $4.84M derived: sum of 4 quarters · filed 2021-09-01 | ||||
| 2020-04-30 | $1.23M 10-Q · filed 2021-06-10 | $2.72M 10-Q · filed 2021-06-10 | $3.59M derived: sum of 3 quarters · filed 2021-06-10 | $4.68M derived: sum of 4 quarters · filed 2021-06-10 | ||||
| 2020-01-31 | $1.49M 10-Q · filed 2021-03-11 | $2.36M derived: sum of 2 quarters · filed 2021-03-11 | $3.45M derived: sum of 3 quarters · filed 2021-03-11 | $4.72M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2019-10-31 | $871.19K derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-07 | $1.96M derived: sum of 2 quarters · filed 2021-01-07 | $3.23M derived: sum of 3 quarters · filed 2021-01-07 | $5.47M 10-K · filed 2021-01-07 | ||||
| 2019-07-31 | $1.09M 10-Q · filed 2020-09-08 | $2.35M derived: sum of 2 quarters · filed 2020-09-08 | $4.60M 10-Q · filed 2020-09-08 | $7.04M derived: sum of 4 quarters · filed 2020-09-08 | ||||
| 2019-04-30 | $1.27M 10-Q · filed 2020-06-09 | $3.52M 10-Q · filed 2020-06-09 | $5.95M derived: sum of 3 quarters · filed 2020-06-09 | $8.89M derived: sum of 4 quarters · filed 2020-06-09 | ||||
| 2019-01-31 | $2.25M 10-Q · filed 2020-03-09 | $4.68M derived: sum of 2 quarters · filed 2020-03-09 | $7.62M derived: sum of 3 quarters · filed 2020-03-09 | $8.28M derived: sum of 4 quarters · filed 2020-03-09 | ||||
| 2018-10-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09 | $5.37M derived: sum of 2 quarters · filed 2020-01-09 | $6.04M derived: sum of 3 quarters · filed 2020-01-09 | $6.81M 10-K · filed 2020-01-09 | ||||
| 2018-07-31 | $2.94M 10-Q · filed 2019-09-06 | $3.60M derived: sum of 2 quarters · filed 2019-09-06 | $4.38M 10-Q · filed 2019-09-06 | $4.73M derived: sum of 4 quarters · filed 2019-09-06 | ||||
| 2018-04-30 | $660.19K 10-Q · filed 2019-06-12 | $1.44M 10-Q · filed 2019-06-12 | $1.79M derived: sum of 3 quarters · filed 2019-06-12 | $2.15M derived: sum of 4 quarters · filed 2019-06-12 | ||||
| 2018-01-31 | $777.87K 10-Q · filed 2019-03-13 | $1.13M derived: sum of 2 quarters · filed 2019-03-13 | $1.49M derived: sum of 3 quarters · filed 2019-03-13 | $1.92M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-10-31 | $351.83K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-11 | $714.80K derived: sum of 2 quarters · filed 2019-01-11 | $1.15M derived: sum of 3 quarters · filed 2019-01-11 | $1.60M 10-K · filed 2019-01-11 | ||||
| 2017-07-31 | $362.97K 10-Q · filed 2018-09-07 | $794.09K derived: sum of 2 quarters · filed 2018-09-07 | $1.25M 10-Q · filed 2018-09-07 | $1.66M derived: sum of 4 quarters · filed 2018-09-07 | ||||
| 2017-04-30 | $431.12K 10-Q · filed 2018-06-11 | $882.75K 10-Q · filed 2018-06-11 | $1.30M derived: sum of 3 quarters · filed 2018-06-11 | $1.59M derived: sum of 4 quarters · filed 2018-06-11 | ||||
| 2017-01-31 | $451.63K 10-Q · filed 2018-03-09 | $865.12K derived: sum of 2 quarters · filed 2018-03-09 | $1.16M derived: sum of 3 quarters · filed 2018-03-09 | $1.55M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-10-31 | $413.49K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-09 | $705.55K derived: sum of 2 quarters · filed 2018-01-09 | $1.10M derived: sum of 3 quarters · filed 2018-01-09 | $1.56M 10-K · filed 2018-01-09 | ||||
| 2016-07-31 | $292.06K 10-Q · filed 2017-09-08 | $684.65K derived: sum of 2 quarters · filed 2017-09-08 | $1.14M 10-Q · filed 2017-09-08 | |||||
| 2016-04-30 | $392.59K 10-Q · filed 2017-05-26 | $850.91K 10-Q · filed 2017-05-26 | ||||||
| 2016-01-31 | $458.05K 10-Q · filed 2017-03-16 | |||||||
| 2015-10-31 | $711.39K 10-K · filed 2016-12-08 | |||||||
| 2012-10-31 | $499.20K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2014-01-17 | $957.62K derived: sum of 2 quarters · filed 2014-01-17 | $1.56M derived: sum of 3 quarters · filed 2014-01-17 | $2.21M 10-K/A · filed 2014-01-17 | ||||
| 2012-07-31 | $458.41K 10-Q/A · filed 2013-09-20 | $1.06M derived: sum of 2 quarters · filed 2013-09-20 | $1.71M 10-Q/A · filed 2013-09-20 | $2.45M derived: sum of 4 quarters · filed 2013-09-20 | ||||
| 2012-04-30 | $604.21K 10-Q/A · filed 2013-06-19 | $1.25M 10-Q/A · filed 2013-06-19 | $1.99M derived: sum of 3 quarters · filed 2013-06-19 | $2.87M derived: sum of 4 quarters · filed 2013-06-19 | ||||
| 2012-01-31 | $649.68K 10-Q/A · filed 2013-03-25 | $1.39M derived: sum of 2 quarters · filed 2013-03-25 | $2.27M derived: sum of 3 quarters · filed 2013-03-25 | $3.00M derived: sum of 4 quarters · filed 2013-03-25 | ||||
| 2011-10-31 | $736.41K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | $1.62M derived: sum of 2 quarters · filed 2013-01-29 | $2.35M derived: sum of 3 quarters · filed 2013-01-29 | $3.12M 10-K · filed 2013-01-29 | ||||
| 2011-07-31 | $879.64K 10-Q · filed 2012-09-14 | $1.61M derived: sum of 2 quarters · filed 2012-09-14 | $2.39M 10-Q · filed 2012-09-14 | $3.18M derived: sum of 4 quarters · filed 2012-09-14 | ||||
| 2011-04-30 | $731.81K 10-Q · filed 2012-06-14 | $1.51M 10-Q · filed 2012-06-14 | $2.30M derived: sum of 3 quarters · filed 2012-06-14 | $2.97M derived: sum of 4 quarters · filed 2012-06-14 | ||||
| 2011-01-31 | $776.91K 10-Q · filed 2012-03-16 | $1.56M derived: sum of 2 quarters · filed 2012-03-16 | $2.24M derived: sum of 3 quarters · filed 2012-03-16 | |||||
| 2010-10-31 | $787.93K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-01-30 | $1.46M derived: sum of 2 quarters · filed 2012-01-30 | $3.01M 10-K · filed 2012-01-30 | |||||
| 2010-07-31 | $673.32K 10-Q/A · filed 2011-10-14 | $2.22M 10-Q/A · filed 2011-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |